Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × binimetinib × Dermatologic × Clear all

Phase

Phase 2 19 Phase 1 7 Phase 1/2 6 Phase 3 4 Phase EARLY_PHASE1 2 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Dermatologic 1

Conditions

Interventions

Imiquimod 14 Aminolevulinic Acid 7 Diclofenac 6 3-ingenyl angelate 6 Fluorouracil 5 Cryotherapy 5 tirbanibulin 4 Sirolimus 4 Nivolumab 4 methyl 5-aminolevulinate 3 denileukin diftitox 3 aldesleukin 3 Photochemotherapy 3 Blood Specimen Collection 3 Vemurafenib 2 Tacrolimus 2 Prednisone 2 Ointments 2 Methotrexate 2 Ipilimumab 2 HhAntag691 2 Gels 2 Cyclosporine 2 Cryosurgery 2 trametinib 1 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 technetium Tc 99m nanocolloid 1 sargramostim 1 relatlimab 1 prednylidene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092410 2025-07-29

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡